Gestational (or A2) diabetes is a type of diabetes that develops during pregnancy. It is caused by a temporary change in the way the body makes and uses insulin. This change can cause high blood sugar levels for the mother and her unborn baby. The cause of A2 gestational diabetes is unknown. However, some factors can increase the risk, such as being overweight or obese before pregnancy, having a close family member with diabetes, or having an ethnicity associated with a higher risk of diabetes. A2 gestational diabetes can have serious consequences for the mother and baby. High blood sugar levels can lead to a larger baby, which can lead to a longer and more difficult labor and delivery. In addition, the baby may be at risk for developing low blood sugar shortly after birth. In order to diagnose gestational diabetes, the doctor may recommend a glucose challenge test or a glucose tolerance test. These tests can help identify high blood sugar levels. If gestational diabetes is diagnosed, the doctor will usually recommend lifestyle changestype and sometimes medications to help manage the condition. These changes include eating a healthy diet, exercising regularly, and monitoring blood sugar levels. In some cases, insulin injections may be necessary to help control blood sugar levels. It is important to note that A2 gestational diabetes generally resolves after pregnancy. However, women who have had gestational diabetes are at an increased risk of developing type 2 diabetes later in life. Therefore, it is important for these women to have regular checkups and to make lifestyle changes to help prevent the development of diabetes.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia